ICU MEDICAL INCICUIEarnings & Financial Report
ICU Medical, Inc. is a medical technology company based in San Clemente, California. ICU Medical products are designed to prevent bloodstream infections and protect healthcare workers from exposure to infectious diseases or hazardous drugs. ICU Medical product line includes intravenous therapy (IV) products, pumps, needle-free vascular access devices, custom infusion sets, closed system hazardous drug handling devices and systems, sensor catheters, needle-free closed blood sampling systems, a...
Revenue
$548.9M
Gross Profit
$208.1M
Operating Profit
$10.6M
Net Profit
$35.3M
Gross Margin
37.9%
Operating Margin
1.9%
Net Margin
6.4%
YoY Growth
-8.0%
EPS
$1.43
ICU MEDICAL INC Q2 FY2025 Financial Summary
ICU MEDICAL INC reported revenue of $548.9M (down 8.0% YoY) for Q2 FY2025, with a net profit of $35.3M (up 265.1% YoY) (6.4% margin). Cost of goods sold was $340.8M, operating expenses totaled $197.5M.
Key Financial Metrics
| Total Revenue | $548.9M |
|---|---|
| Net Profit | $35.3M |
| Gross Margin | 37.9% |
| Operating Margin | 1.9% |
| Report Period | Q2 FY2025 |
Revenue Breakdown
ICU MEDICAL INC Q2 FY2025 revenue of $548.9M breaks down across 4 segments, led by Infusion Consumables at $273.1M (49.8% of total).
| Segment | Revenue | % of Total |
|---|---|---|
| Infusion Consumables | $273.1M | 49.8% |
| Infusion Systems | $167.7M | 30.6% |
| Vital Care | $108.0M | 19.7% |
| Equity Method Investee | $3.5M | 0.6% |
ICU MEDICAL INC Revenue by Segment — Quarterly Trend
ICU MEDICAL INC revenue by segment across the last 4 reported quarters, showing how each business line (such as Infusion Consumables and Infusion Systems) has evolved quarter over quarter.
| Segment | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 |
|---|---|---|---|---|
| Infusion Consumables | $284.7M | $285.1M | $273.1M | $266.2M |
| Infusion Systems | $176.3M | $173.9M | $167.7M | $166.3M |
| Vital Care | $79.7M | $78.0M | $108.0M | $172.2M |
| Equity Method Investee | — | $3.6M | $3.5M | — |
ICU MEDICAL INC Annual Revenue by Year
ICU MEDICAL INC annual revenue history includes year-by-year totals (for example, 2025 revenue was $2.2B).
| Year | Annual Revenue |
|---|---|
| 2025 | $2.2B |
| 2024 | $2.4B |
| 2023 | $2.3B |
| 2022 | $2.3B |
ICU MEDICAL INC Quarterly Revenue & Net Profit History
ICU MEDICAL INC results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 FY2025 | $540.7M | -14.1% | $-15.7M | -2.9% |
| Q3 FY2025 | $537.0M | -8.9% | $-3.4M | -0.6% |
| Q2 FY2025 | $548.9M | -8.0% | $35.3M | 6.4% |
| Q1 FY2025 | $604.7M | +6.7% | $-15.5M | -2.6% |
| Q4 FY2024 | $629.8M | +7.1% | $-23.8M | -3.8% |
| Q3 FY2024 | $589.1M | +6.5% | $-33.0M | -5.6% |
| Q2 FY2024 | $596.5M | +8.6% | $-21.4M | -3.6% |
| Q1 FY2024 | $566.7M | -0.4% | $-39.5M | -7.0% |
Income Statement
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $566.7M | $596.5M | $589.1M | $629.8M | $604.7M | $548.9M | $537.0M | $540.7M |
| YoY Growth | -0.4% | 8.6% | 6.5% | 7.1% | 6.7% | -8.0% | -8.9% | -14.1% |
Balance Sheet
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $4.29B | $4.29B | $4.31B | $4.20B | $4.18B | $4.11B | $4.10B | $4.05B |
| Liabilities | $2.22B | $2.25B | $2.26B | $2.24B | $2.20B | $1.99B | $1.98B | $1.93B |
| Equity | $2.07B | $2.04B | $2.05B | $1.97B | $1.99B | $2.12B | $2.13B | $2.12B |
Cash Flow
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $45.8M | $82.0M | $36.1M | $40.2M | $51.3M | $11.2M | $56.7M | $60.6M |